Kristine Peterson
Director/Board Member chez IMMUNOCORE HOLDINGS PLC
Fortune : - $ au 31/03/2024
Profil
Kristine Peterson is an Independent Director at Enanta Pharmaceuticals, Inc., Director at Greater Philadelphia Life Sciences Congress, Director at AFYX Therapeutics AS, and Non-Executive Director at Immunocore Holdings Plc and Immunocore Ltd.
She was the Chief Executive Officer at Valeritas Holdings, Inc. and Valeritas, Inc. from 2009 to 2016.
She was also the Group Chairman-Biotech Groups at Johnson & Johnson from 2006 to 2009.
She is an Independent Director at ImmunoGen, Inc. since 2012 and an Independent Non-Executive Director at Amarin Corp.
Plc since 2010.
She was a Director at Biotechnology Innovation Organization and an Independent Non-Executive Director at EyePoint Pharmaceuticals, Inc. from 2017 to 2020.
She is an Independent Director at Paratek Pharmaceuticals, Inc. since 2016.
She was a President & Senior VP-Commercial Operations at Biovail Corp.
and President at Biovail Pharmaceuticals LLC from 2003 to 2004.
She received her undergraduate degree and MBA from the University of Illinois At Urbana–Champaign in 1981 and 1983, respectively.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMUNOCORE HOLDINGS PLC
-.--% | 02/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
| 06/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Kristine Peterson
| Sociétés | Poste | Début |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Director/Board Member | 13/09/2017 |
| IMMUNOCORE HOLDINGS PLC | Director/Board Member | 01/11/2017 |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The private company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Director/Board Member | - |
| Greater Philadelphia Life Sciences Congress | Director/Board Member | 08/04/2011 |
AFYX Therapeutics AS
 AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | Director/Board Member | - |
Anciens postes connus de Kristine Peterson
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUNOGEN, INC. | Director/Board Member | 12/02/2024 |
| PARATEK PHARMACEUTICALS, INC. | Director/Board Member | 21/09/2023 |
| AMARIN CORPORATION PLC | Director/Board Member | 06/03/2023 |
| EYEPOINT PHARMACEUTICALS, INC. | Director/Board Member | 31/12/2020 |
| ░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Kristine Peterson
| University of Illinois At Urbana–Champaign | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 8 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| IMMUNOGEN, INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| AMARIN CORPORATION PLC | Health Technology |
| EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
| ENANTA PHARMACEUTICALS, INC. | Health Technology |
| PARATEK PHARMACEUTICALS, INC. | Health Technology |
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| Entreprise privées | 8 |
|---|---|
Biovail Corp.
 Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Valeritas Holdings, Inc.
 Valeritas Holdings, Inc. Medical SpecialtiesHealth Technology Valeritas Holdings, Inc. develops and commercializes insulin delivery devices. The company was founded by Leisa Swanson and Robert R. Gonnelli on August 2, 2006 and is headquartered in Bridgewater, NJ. | Health Technology |
Biovail Pharmaceuticals LLC
 Biovail Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Biovail Pharmaceuticals, Inc. researches and develops pharmaceutical medicines. The company products include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. The company is headquartered in Bridgewater, NJ. | Health Technology |
| Greater Philadelphia Life Sciences Congress | |
AFYX Therapeutics AS
AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | Commercial Services |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The private company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Health Technology |
Valeritas, Inc.
 Valeritas, Inc. Medical SpecialtiesHealth Technology Valeritas, Inc. engages in the development and commercialization of drug delivery solutions for the treatment of diabetes. Its product, V-Go wearable insulin delivery device, which enables patients to closely mimic the body’s normal physiologic pattern of insulin delivery by using one type of insulin at a continuous preset basal rate over a 24-hour period and provides on-demand bolus dosing for meals and snacks. The company was founded on August 2, 2006 and is headquartered in Bridgewater, NJ. | Health Technology |
